Company Completely Halts Generic Lipitor Production After Recall
Indian generic drugmaker Ranbaxy Laboratories will stop manufacturing its version of Pfizer Inc's cholesterol fighter, Lipitor, while it gets to the bottom of the cause of a recent recall, the U.S. Food and Drug Administration said on its website.
Join the discussion below, or Read more at The Huffington Post.
#1 Dec 6, 2012
No matter what the result of Ranbaxy's invesigation,it will lose 90% of its generic atorvastating business in the US. market which would have been $ 150 mm +in 2013.
Add your comments below
|Ranbaxy announces USFDA approval of CIP-Isotret... (Aug '12)||Sep '13||De Croft||9|
|Mylan Inc. Tries to Get Its Hands on Ranbaxy La... (Dec '12)||Dec '12||Jrseyan||1|
Find what you want!
Search Ranbaxy Laboratories Forum Now
Copyright © 2016 Topix LLC